Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Rare Histiocytic Disorders Registry (IRHDR)

NCT02285582 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02285582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02285582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Rare Histiocytic Disorders Registry (IRHDR)
Lead sponsor
The Hospital for Sick Children
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2014
Completion date
September 30, 2028
Enrollment
400 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

alk-positive histiocytosis, erdheim-chester disease (ecd), indeterminate dendritic cell histiocytosis, malignant histiocytic neoplasm (mhn), mixed histiocytosis (mxh), multicentric reticulohistiocytoma (mrh), necrobiotic xanthogranuloma (nx), rare histiocytic disorders (rhds), rosai-dorfman disease (rdd), xanthogranuloma family (xg)